Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

JAN 23, 2014 - Yahoo! News

A Must Read - Share

Amgen cholesterol drug meets goal of third late stage trial

(Reuters) - A cholesterol fighter developed by Amgen Inc from a new class of medicines succeeded in significantly lowering levels of "bad" LDL cholesterol in a late stage trial in patients unable to tolerate statin drugs, the company said on Thursday. The results marked the third successful Phase III test of the drug evolocumab reported by Amgen in recent months - this one in a patient population among the most in need of alternative therapies. Evolocumab belongs to a class of medicine called PCSK9 inhibitors that work by blocking a protein that reduces the liver's ability to remove LDL ... Read More

Tags: Amgen cholesterol drug meets goal of third late stage trial,  Amgen Latest News